Myriad Genetics Survey Reveals Women's Concerns on Screenings
Understanding Women's Perspectives on Health Screenings
Recent findings from Myriad Genetics, a leader in molecular diagnostic testing (NASDAQ: MYGN), have shed light on the perceptions of women regarding health screenings. These insights emerged from their latest Cancer Risk Survey, revealing a surprising contradiction in women's views toward screening practices.
Fear Versus Reassurance
Despite 80% of women expressing fear about undergoing screenings—mainly due to anxiety over possible results—75% reported that such screenings, including genetic testing, could provide peace of mind if they faced potential health challenges. This duality in perception emphasizes the significant need for improved understanding and communication surrounding advanced screening tools that can empower women, especially those at higher risk for hereditary cancers.
Expert Insights on Overcoming Fear
Dr. Ifeyinwa Stitt, an OB/GYN and medical director at Caronette Fibroid & Pelvic Wellness Center, notes, "Many women find health screenings frightening due to the uncertainty surrounding them. Although these screenings are integral to healthcare, the emotional aspect cannot be overlooked." Dr. Stitt encourages women to confront their fears, particularly regarding genetic testing, which holds the potential to save lives by informing them about their health risks.
Awareness of Genetic Testing
According to the survey, only about 37% of women believe that genetic testing could aid in managing breast health. Furthermore, nearly 40% were unaware of the existence of such tools to assess their personal risks for breast cancer. Alarmingly, a mere 14% of women have ever undergone genetic testing, while more than one in four women in OB/GYN practices are eligible for hereditary cancer testing.
The Role of Genetic Tests
Genetic tests, such as the MyRisk® Hereditary Cancer Test with RiskScore®, offer vital insights into a patient's hereditary risk for certain cancers. This information can lead to additional screenings, including increased surveillance through more frequent mammograms or MRIs. Dr. Stitt emphasizes the importance of clear communication regarding genetic testing to integrate it effectively into women's healthcare plans.
The Significance of Family Health History
Understanding one's family health history is another crucial factor in gauging cancer risk. Over half of the survey participants believe it is paramount to know their parents' health history; however, only about 30% reported a thorough understanding of it. Additionally, about half of the participants stated they would advise their younger selves to engage in more discussions with their parents regarding their health.
Familial Factors Affecting Risk Assessment
Women should recognize the importance of various familial factors, including multiple cancers within the family, the age at which family members were diagnosed, and the presence of rare cancers like pancreatic or ovarian cancer, which can indicate a potential benefit from hereditary cancer testing. By combining this knowledge with genetic insights and other clinical factors, the MyRisk Hereditary Cancer Test with RiskScore can predict a woman's five-year and lifetime risk for breast cancer.
Empowering Women Through Knowledge
If a woman is identified as being at high risk for breast cancer, she is presented with numerous options, including modifications to her medical management and increased screening frequency. For more details on understanding personal breast cancer risk, women are encouraged to explore resources that can guide their health decisions.
Frequently Asked Questions
What does the Myriad Genetics survey focus on?
The survey examines women's attitudes toward health screenings and genetic testing, revealing their fears and the reassurance these tools can provide.
Why are women apprehensive about screenings?
Many women fear screenings due to the anxiety about what the results may reveal about their health status.
What percentage of women are aware of genetic testing?
Approximately 40% of women surveyed reported being unaware that genetic testing exists to help evaluate their individual risk levels for breast cancer.
How can genetic testing impact a woman's health management?
Genetic testing can lead to more personalized health management strategies, including changes in screening frequency based on the identified risk.
What factors influence cancer risk understanding?
Family health history, including cancers diagnosed at certain ages or the presence of rare cancers, plays a critical role in assessing cancer risk.
About The Author
Contact Dylan Bailey privately here. Or send an email with ATTN: Dylan Bailey as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.
